Founded in
2016
Description
SHORT DESCRIPTION:
MaxWell Biosystems develops technologies to boost basic neuroscience research and speed up the development of preclinical drugs. MaxOne, an electrophysiological platform for recording and activating electrogenic cells in vitro, is one of the company’s products. With 26,400 electrodes, 1024 low-noise readout channels, and 32 stimulation channels, it’s a CMOS-based high-density microelectrode array. It facilitates phenotypic screening and pharmacological toxicity/efficacy testing by collecting single cell and network characteristics.
LONG DESCRIPTION:
Based in
Basel
Nation
Founding Status
$ 2.5 Millions - $ 5 Millions
Add a review